Grantee Profile
The IFOPA and FOP Friends® UK Fund New Research at University of Oxford
Read moreRegeneron Shares Updates on its Ongoing FOP Research Program
Potentially Promising Treatment for FOP
We are pleased to share a few exciting updates on our ongoing work to help improve the lives of people with FOP.
Read moreReflections on the Year: 2016
Michelle Davis Looks Back on 2016
Read moreGenerous Matching Gift
Special Matching Gift Opportunity for Year-End IFOPA Supporters
Read moreBipartisan Support
21st Century Cures Legislation Signed by President Obama
On December 7, the Senate followed the House of Representative's lead and signed the 21st Century Cures bill which is focused on developing treatments and cures for rare diseases; President Obama signed it on December 13.
Read moreExciting Changes for 2017
Growing our ability to deliver on the IFOPA's mission
Read moreThree new Clementia sites now open for Part B of the Phase 2 Open-label Extension Trial
Approval of 3 New Sites!
The participation of individuals living with FOP in clinical studies and trials is key to FOP drug development efforts.
Read more